Document Detail


Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy.
MedLine Citation:
PMID:  20679166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare intranasal midazolam, using a Mucosal Atomization Device (IN-MMAD), with rectal diazepam (RD) for the home treatment of seizures in children with epilepsy. DESIGN: Prospective randomized study. SETTING: Patients' homes and a freestanding children's hospital that serves as a referral center for 5 states. PATIENTS: A total of 358 pediatric patients who visited a pediatric neurology clinic from July 2006 through September 2008 and were prescribed a home rescue medication for their next seizure. INTERVENTION: Caretakers were randomized to use either 0.2 mg/kg of IN-MMAD (maximum, 10 mg) or 0.3 to 0.5 mg/kg of RD (maximum, 20 mg) at home for their child's next seizure if it lasted more than 5 minutes. OUTCOME MEASURES: The primary outcome measure was total seizure time after medication administration. Our secondary outcome measures were total seizure time, time to medication administration, respiratory complications, emergency medical service support, emergency department visits, hospitalizations, and caretakers' ease of administration and satisfaction with the medication. RESULTS: A total of 92 caretakers gave the study medication during a child's seizure (50 IN-MMAD, 42 RD). The median time from medication administration to seizure cessation for IN-MMAD was 1.3 minutes less than for RD (95% confidence interval, 0.0-3.5 minutes; P=.09). The median time to medication administration was 5.0 minutes for each group. No differences in complications were found between treatment groups. Caretakers were more satisfied with IN-MMAD and report that it was easier to give than RD. CONCLUSIONS: There was no detectable difference in efficacy between IN-MMAD and RD as a rescue medication for terminating seizures at home in pediatric patients with epilepsy. Ease of administration and overall satisfaction was higher with IN-MMAD compared with RD. Trial Registration clinicaltrials.gov Identifier: NCT00326612.
Authors:
Maija Holsti; Nanette Dudley; Jeff Schunk; Kathleen Adelgais; Richard Greenberg; Cody Olsen; Aaron Healy; Sean Firth; Francis Filloux
Related Documents :
17088106 - Medical decision-making abilities in older adults with chronic partial epilepsy.
7196546 - Amitriptyline-induced ophthalmoplegia.
9637596 - Multiple subpial transection in patients with extratemporal epilepsy.
1843176 - Vincent's violent vertigo. an analysis of the original diagnosis of epilepsy vs. the cu...
17088106 - Medical decision-making abilities in older adults with chronic partial epilepsy.
20853066 - Medical care needs of returning veterans with ptsd: their other burden.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of pediatrics & adolescent medicine     Volume:  164     ISSN:  1538-3628     ISO Abbreviation:  Arch Pediatr Adolesc Med     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-03     Completed Date:  2010-08-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9422751     Medline TA:  Arch Pediatr Adolesc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  747-53     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108, USA. maija.holsti@hsc.utah.edu
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00326612
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Administration, Intranasal
Administration, Rectal
Anticonvulsants / administration & dosage*
Child
Child, Preschool
Diazepam / administration & dosage*
Double-Blind Method
Epilepsy / drug therapy*
Female
Home Care Services
Humans
Male
Midazolam / administration & dosage*
Nebulizers and Vaporizers
Prospective Studies
Chemical
Reg. No./Substance:
0/Anticonvulsants; 439-14-5/Diazepam; 59467-70-8/Midazolam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of a mentoring and skills group program on mental health outcomes for maltreated children in ...
Next Document:  Child Hunger and Long-term Adverse Consequences for Health.